About Unlearn.AI

Unlearn AI is a healthcare-focused artificial intelligence company that builds “digital twins” of patients to improve clinical trials. It helps pharmaceutical and biotech companies simulate patient outcomes using AI so they can design faster, smaller, and more efficient clinical studies. The main goal is to reduce trial time, cost, and uncertainty in drug development by predicting patient health outcomes more accurately.

Platforms:

Feature Highlights

Use Cases

Common
Uncommon
Description
Designing and optimizing clinical trials for pharmaceutical companies
Reducing the number of patients needed in control groups
Speeding up drug development in diseases like Alzheimer’s, oncology, and metabolic disorders
Testing trial outcomes before actual patient enrollment
Improving statistical power and reliability of medical studies
Helping biotech companies make faster go/no-go decisions